USEF Approves New Drug for Horses
Equestrian News Release
The United States Equestrian Federation (USEF) has approved the use of the new Non-Steroidal Anti-Inflammatory Drug (NSAID) EQUIOXX® (firocoxib) from August 1, 2007. Until this time, the use of firocoxib is restricted to use outside competition. This new NSAID is the first highly COX-1 sparing drug to be FDA approved for use in horses.
The new rule lists firocoxib as a NSAID with a restrictive quantitative limit, and allows for a maximum permitted concentration of 0.240 micrograms per milliliter of blood plasma. The recommendation for appropriate dose and time consideration is to follow the manufacturer’s guidelines for its use at 0.1 milligram per kilogram of body weight once daily. This corresponds with a 45.5 milligram dose for a 1000 lb. horse, and should be given no sooner than 12 hours prior to competing. Firocoxib is permitted to be used for a period of 14 consecutive days. Firocoxib should not be used in a horse in the 30 days prior to competing in an International Equestrian Federation (FEI) sanctioned event until further review by the FEI, per manufacturer recommendation.
Courtesy: The HorseTV Channel News, http://www.horsetv.com
Reader Comments
Be the first to submit a comment on this article!
Submit your comments
Link to this article
---------------------- It's easy! Just copy code below and paste into your webpage --------------------
<a href="http://www.equestrianmag.com/article/usef-approves-new-drug-horse-7-07.html">USEF Approves New Drug for Horses</a> ~ EquestrianMag.com
----------------------------------------------------------------------------------------------------------------------------------
Your link will appear like this:
USEF Approves New Drug for Horses ~ EquestrianMag.com
|
